Leader for New Ziment Division

IMAP Research, the new multi-client studies division of The Ziment Group announced on Friday, will have Mike Kelly as its first President. Kelly's previous work includes roles at Merck, Johnson & Johnson and TargetRx.

Kelly has over 15 years of experience in the pharmaceutical and healthcare industries including marketing, market research and sales leadership roles. Most recently, he ran a private consulting practice advising pharmaceutical and biotechnology companies on MR needs for key brands nearing launch. He starts at IMAP on December 1st.

Ziment, the global healthcare research brand for The Kantar Group, is online at www.ziment.com

All articles 2006-23 written and edited by Mel Crowther and/or Nick Thomas, 2024- by Nick Thomas, unless otherwise stated.

• Ziment Group
• All news